Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

China expands curbs on fentanyl, blames U.S. for its abuse

China will expand the range of fentanyl-related substances the country defines as controlled narcotics, a Chinese security official said, blaming U.S. culture for abuse of the drug.

Read More »

U.S. sues to block Philadelphia safe drug-injection site

The U.S. Justice Department filed a lawsuit seeking to stop a nonprofit in Philadelphia from opening what could become the nation’s first supervised drug-injection site in an effort aimed at addressing opioid abuse.

Read More »

Ex-Insys CEO to plead guilty to opioid kickback scheme

The former chief executive of Insys Therapeutics Inc. agreed to plead guilty to participating in a scheme to bribe doctors.

Read More »

Opioid maker Insys paid kickbacks to physician assistant, jury hears

A former Insys Therapeutics Inc. sales representative now married to the drugmaker’s ex-CEO said she arranged to have a physician assistant in New Hampshire receive kickbacks to prescribe patients its addictive fentanyl spray.

Read More »

Trump to sign anti-opioid abuse package

Medical treatment would be more widely available to opioid abusers under a rare bipartisan measure aimed at tackling the U.S. addiction crisis expected to be signed into law by President Trump.

Read More »

Maryland charges Insys with engaging in deceptive opioid scheme

Maryland charged Insys Therapeutics Inc. with deceptively marketing a powerful opioid pain killer so that it was prescribed inappropriately beyond its intended use with cancer patients.

Read More »

Emergent BioSolutions to buy Narcan maker Adapt Pharma

Emergent BioSolutions will buy privately held Adapt Pharma, beefing up its portfolio with Narcan, the only FDA-approved needle-free emergency opioid overdose treatment.

Read More »

China says United States domestic opioid market the crux of crisis

China’s drug control agency on Monday said the United States should do more to cut its demand for opioids to tackle the use of the synthetic drug fentanyl, but it vowed to step up cooperation after Chinese production of the substance was blamed for fueling the U.S. opioid crisis.

Read More »

Opioids no better than NSAIDs for chronic back or arthritis pain

Acetaminophen, ibuprofen and other nonsteroidal anti-inflammatory drugs (NSAIDs) are better than opioids at easing the intensity of chronic pain in the back, knees or hips, a U.S. experiment suggests.

Read More »

Maryland sues Insys to enforce subpoena in opioid probe

Maryland’s attorney general filed a lawsuit seeking to enforce a subpoena the state sent Insys Therapeutics Inc. as part of a probe into allegations the drugmaker deceptively marketed a fentanyl-based cancer pain medicine.

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

April 2019 Focus: Healthcare agency & network profiles, industry overview & awards, and more!

Subscribe

Ad Right Bottom